tirzepatide surpass-5 reduces albuminuria among adults with type 2 diabetes in SURPASS trials Systolic blood pressure reduction with
Description
Improved cardiometabolic health Tirzepatide improves your cardiometabolic health by addressing risk factors, including high blood sugar, excess weight, and poor cholesterol levels
Infine, analisi in real-world (DOM 2024) confermano lefficacia della tirzepatide in ambito non sperimentale, con una perdita media di -15% a 6 mesi , miglioramento della qualit della vita e dei parametri cardiometabolici (Diabetes Therapy, 2025)
Competitive and affordable pricing options
The pricing is competitive, especially on longer plans: $283/month for tirzepatide on the 12-month plan
